court ruling

The Broad Institute's lawyers used statements from Jennifer Doudna to undermine UC's case that one could expect CRISPR/Cas9 to work in eukaryotic cells.

The University of California-led party can still appeal the decision from the US Patent and Trademark Office, but it has been dealt a major setback.

The Australian High Court rules that isolated genetic material cannot be patented.

The court held that an isolated nucleic acid sequence is not a manner of manufacture and cannot form the basis of a valid patent.

NEW YORK (GenomeWeb News) – The US Supreme Court today unanimously ruled that human genes are not patentable, but synthetic DNA, or cDNA, is patent eligible because it does not occur naturally.

NEW YORK (GenomeWeb News) – In a patent infringement suit between Illumina and Complete Genomics, the US District Court for the Northern District of California this week denied a motion by Illumina to reconsider a judgment the court rendered in favor of Complete Genomics last October.

NEW YORK (GenomeWeb News) – A German court has ruled in favor of Agilent Technologies in a patent infringement case against Waters dating back to 2005, Waters disclosed in its Form 10-K.

NEW YORK (GenomeWeb News) – The Federal Court of Australia has dismissed a case in which a group of cancer patients were challenging the viability of a patent held by Myriad Genetics covering mutations in the BRCA1 gene linked to increased risk of hereditary breast and ovarian cancer.

NEW YORK (GenomeWeb News) – The US District Court for the Northern District of California has agreed to reconsider part of its recent ruling in a patent dispute between Illumina and Complete Genomics, Illumina said today.

NEW YORK (GenomeWeb News) – A court has thrown out a lawsuit filed against Vermillion by dissident shareholders, allowing the company to proceed with its annual meeting, Vermillion said Monday.

Pages

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.